CHIP could function as a tumor suppressor by regulating and degrading epidermal growth factor receptor (EGFR) in pancreatic cancer [5], RelA in gastrointestinal cancer [6, 7], and c-Myc in glioma [8]. Here, EGFR is linked to central nervous system cancer.